The American Society of Hematology has revised its clinical recommendations to assist physicians in detecting iron deficiency sooner through raised ferritin levels in blood analysis. The updated standards seek to enhance diagnostic accuracy for various demographics, such as adults, toddlers, people experiencing inflammation, and those who menstruate or are pregnant.
Revised Ferritin Benchmarks
Ferritin, the protein that stores iron, plays a critical role in hemoglobin production—the compound responsible for transporting oxygen. Without intervention, the ASH cautions that iron deficiency may advance to iron deficiency anemia, which diminishes hemoglobin and triggers symptoms like exhaustion, frailty, lightheadedness, and cognitive impairment.
The new protocol establishes revised ferritin measurements as diagnostic markers, indicating insufficient iron when levels fall below specified values. For infants and toddlers aged nine months to four years, the cutoff is 20 ng/mL or less. Adults and menstruating or pregnant individuals should have levels no lower than 30 ng/mL.
Those at raised risk, such as individuals with excessive menstrual bleeding or pregnant women with anemia, must maintain ferritin levels exceeding 50 ng/mL. Adults with inflammatory conditions, including cancer, inflammatory bowel disease, or infections, require serum ferritin below 100 ng/mL or transferrin saturation under 20%.
Combating a Widespread Health Issue
Despite iron deficiency being among the world’s most prevalent health concerns, the ASH notes that many individuals endure symptoms for extended periods before diagnosis. The organization estimates the condition affects roughly 10 million U.S. adults and over two billion people globally.
High-risk groups, such as pregnant or menstruating individuals, children, and those with gastrointestinal disorders, dietary limitations, blood loss, or chronic illnesses, face greater susceptibility. Yet up to 70% of cases in these populations remain undetected due to insufficient screening and inconsistent diagnostic criteria.
“Iron deficiency and its associated anemia represent some of the most widespread yet overlooked medical conditions worldwide,” states ASH president Robert Negrin, M.D. “Patients often experience fatigue, weakness, dizziness, or concentration difficulties for months or years before the deficiency is identified.”
Read Also: Only two UK kids’ yogurts meet NHS low-sugar standards
“These guidelines represent a key advancement in narrowing that diagnostic gap by enabling clinicians to recognize iron deficiency sooner and with greater precision, ensuring patients access necessary treatment,” Negrin emphasizes.
The ASH’s evidence-backed recommendations appear in Blood Advances, its peer-reviewed journal, and were crafted by specialists across medical fields.
“These updated ferritin thresholds offer much-needed clarity in an area where professional consensus has been scarce,” observes guideline lead Jacquelyn Powers, M.D., hematology section chief at Texas Children’s Hospital and associate professor of pediatrics at Baylor College of Medicine. “Our goal is to help patients advocate for appropriate testing while encouraging healthcare systems to adopt these standards.”
Future Treatment Directions and Innovations
Recent breakthroughs include Lubrizol’s microencapsulation method, designed to enhance iron absorption and digestive tolerance. SloIron’s plant-derived, ferritin-bound iron has also demonstrated effectiveness in delivering iron to both healthy individuals and those with deficiencies.
Scientists are also exploring microbial interventions to optimize iron absorption. A study revealed that Probi’s probiotic strain Lactiplantibacillus plantarum 299v enhances iron bioavailability through mechanisms supporting solubility, uptake, and metabolic regulation.
ASH Guidance Addresses Diagnostic Challenges
The American Society of Hematology is recommending clinicians use blood tests with higher ferritin thresholds to identify iron deficiencies earlier and more accurately, according to new clinical guidance published in Blood Advances. The updated standards aim to improve diagnosis across key populations, including adults, young children, individuals with inflammation, and menstruating or pregnant women.
